Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Acura Pharmaceuticals Inc.

NASDAQ: ACURHealthcare / Drug Delivery / USA
0.49+0.003+0.62%Vol 1 0021Y Perf 6.29%
May 25th, 2018 09:51
BID0.00 ASK0.00
Open0.49 Previous Close0.487
Pre-Market- After-Trading-
 - -%  - -%
Target Price
6.00 
Analyst Rating
— 0.00
Potencial %
1 124.49 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
     20.69
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
     25.82
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)10 
Earnings Rating
Buy
Price Range Ratio 52wk %
34.98 
Earnings Date
1st Jun 2018

Today's Price Range

0.490.49

 

52wk Range

0.2860.87

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
-5.77%
3 Months
-15.53%
6 Months
16.36%
1 Year
6.29%
3 Years
-87.34%
5 Years
-95.86%
Last Quotes
Name / TickerPriceChg.Chg.%
ACUR0.490.00300.62
AAPL188.580.43000.23
GOOG1 075.66-3.5800-0.33
MSFT98.360.05000.05
XOM78.71-1.5600-1.94
WFC54.900.23000.42
JNJ121.470.12000.10
FB184.92-1.0100-0.54
GE14.630.03000.21
JPM110.66-0.5700-0.51
...

TickerPriceChg.%52 Week High
FL55.7420.1660.64
DGX105.814.88112.96
LH182.143.84184.33
LEN53.393.7572.17
ALK61.873.3495.75
LUV52.863.2266.99
AAL44.913.1059.08
RCL109.802.91135.65
K65.232.7174.28
DAL55.872.7060.79
AVGO250.032.67285.68
UA18.882.6621.81
INCY68.432.64140.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.10
Current Ratio 1.20
Long Term Debt to Total Capital 0.30
Total Debt to Equity 2.26
Interest Coverage -2.60
Leverage Ratio 10.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin96.30
EBIT Margin-26.10
EBITDA Margin-21.50
Pre-tax Profit Margin-2 689.90
Profit Margin-36.20
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 5.85
PS Ratios 53.48
Price to Cash Flow 12.10
Price to Free Cash Flow -2.20
Cash Flow Per Share -0.08
Price to Tangible Book28.88
Book Value per Share0.08
Enterprise Value (in ths.)8 190
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-66.48
ROE last 12 Months -442.50
Return on Assets (5Y Avg) -122.30
ROA last 12 Months -31.40
Return on Capital (5Y Avg) -48.00
ROC last 12 Months -31.82
Return on invested Capital Q -44.88
Return on invested Capital Y-58.55
Assets Turnover0.00
Receivables Turnover-0.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)175
Revenue per Share 0.01
Revenue Growth 3 Years -33.66
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2017--0.12-
Q02 2017-0.11-0.18-63.64
Q01 2017-0.110.03127.27
Q04 2016-0.270.13148.15
Q03 2016-0.27-0.1929.63
Q02 2016-0.28-0.280.00
Q01 2016-0.25-0.28-12.00
Q04 2015-0.03-0.08-166.67
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.120.00-
12/2017 QR-0.120.00-
12/2017 FY-0.460.00-
12/2018 FY0.380.00-
Next Report Date1st Jun 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1 002
Shares Outstanding (in ths.)20 800
Trades Count0
Dollar Volume0
Avg. Volume17 057
Avg. Weekly Volume3 960
Avg. Monthly Volume7 910
Avg. Quarterly Volume8 254

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

33%67%

Bearish Bullish

45%55%

Bearish Bullish

56%44%

Bearish Bullish

68%32%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x